Page last updated: 2024-08-21

diphenylamine and Allodynia

diphenylamine has been researched along with Allodynia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, A; Funakami, Y; Ichida, S; Imano, M; Itoh, T; Nishida, S; Ogawa, N; Sakamoto, K; Satou, T; Shimaoka, H; Suzuyama, N; Takeda, T; Tani, T; Tsubaki, M	1

Other Studies

1 other study(ies) available for diphenylamine and Allodynia

Article	Year
PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects. International journal of cancer, 2015, Jul-01, Volume: 137, Issue:1 Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Diphenylamine; Disease Models, Animal; Drug Synergism; Hyperalgesia; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Oxaliplatin; Protein Kinase Inhibitors; Spinal Cord; Tamoxifen	2015

Article

Year

PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects.

International journal of cancer, 2015, Jul-01, Volume: 137, Issue:1

Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Diphenylamine; Disease Models, Animal; Drug Synergism; Hyperalgesia; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Oxaliplatin; Protein Kinase Inhibitors; Spinal Cord; Tamoxifen

2015